The regenerative artificial skin market is projected to reach $3.84B by 2030 at 12.3% CAGR, driven by cell-based therapies, advanced wound care, and personalized skin graft innovations.
Read More
The refurbished cardiovascular and cardiology equipment market is projected to reach $7.43B by 2030 at 9.9% CAGR, driven by cost-optimized care, certified refurbished adoption, and expanding cardiac diagnostics access.
Read More
The recurrent pericarditis market is projected to reach $1.32B by 2030 at 10.8% CAGR, driven by biologic adoption, targeted cytokine inhibitors, specialty cardiology expansion, and structured recurrence prevention.
Read More
The recombinant vaccines market is projected to reach $28.07B by 2030 at 12.2% CAGR, driven by precision vaccines, emerging disease programs, adult boosters, and advanced recombinant platforms.
Read More
The recombinant proteins manufacturing services market is projected to reach $7.12B by 2030 at 14% CAGR, driven by protein therapeutics pipelines, pharma outsourcing, and GMP bioprocessing demand.
Read More
The recombinant human GCSF injection market is projected to reach $5.86B by 2030 at 8.6% CAGR, driven by cancer care demand, biosimilar adoption, and long-acting injectables.
Read More
The quantitative brain function imaging device market is projected to reach $9.3B by 2030 at an 8.9% CAGR, driven by multimodal imaging, functional brain mapping, advanced neuro software, psychiatric diagnostics, and portable monitoring systems.
Read More
The pyoderma gangrenosum treatment market is projected to reach $2.12B by 2030 at a 12.1% CAGR, driven by biologic therapies, combination drug regimens, advanced wound care, personalized treatments, and expanded clinical monitoring.
Read More
The protein language models market is projected to reach $3.05B by 2030 at a 25.7% CAGR, driven by AI-driven protein design, cloud modeling platforms, and accelerated drug discovery workflows.
Read More
The prion disease treatment market is projected to reach $4.15B by 2030 at 6.6% CAGR, driven by precision neurology, novel drug discovery, and advanced prion diagnostics.
Read More